You are here: Home / Central Office (Cordoba Unit) / ADMINISTRATIVE UNIT / León S. Morra: Guide for Contributors (Guide 3)
Friday, 28.04.2017

Leon S. Morra: Invitation to Contribute

Guide 3

 

 

 

Table of contents

Introduction

Historical neuropsychopharmacology dictionary

Historical psychotropic drugs inventory

Photo history of neuropsychopharmacology

Profiles of distinguished neuropsychopharmacologists

Controversies in the history of neuropsychopharmacology

Textbook on the history of neuropsychopharmacology

Discoveries that have not been followed up and experiments that could not be replicated

Information on books in neuropsychopharmacology: classic and current

Biographies, autobiographies and selected writings of neuropsychopharmacologists

Historical perspective:  information from and comments on current publications in            neuropsychopharmacology

Electronic archives in neuropsychopharmacology

Educational e-Books

 

Introduction

INHN website communications operates 12 projects (listed below). As a member, you are invited to contribute essays and vignettes for posting to each of these projects and to participate with your comments, replies and responses in the exchanges which follow the postings.

 

Historical neuropsychopharmacology dictionary

A comprehensive vocabulary of terms used in the different areas of neuropsychopharmacology research, education and clinical practice. Each entry must be self-contained and fully comprehensible without reference to other work. The entry should include (if possible): the name of the person who coined the term and the publication in which it first appeared; the original definition of the term and changes in its definition, if applicable; a description of how the definition was derived (observation, experimentation, logic, etc.); and the first application of the term in neuropsychopharmacology. Each statement in the vignette must be referenced with the original publication(s).

 

Historical psychotropic drugs inventory

Vignettes of drugs with an effect on behavior and mental activity, and/or in use in the pharmacotherapy of psychiatric/neurological disorders, and/or in research in neuropsychopharmacology.  Each entry must be self-contained and fully comprehensible without reference to other work and include information on each step in the development of the product, starting with the synthesis of the substance. Characterization of the final product must be restricted to pharmacological actions recorded by behavioral, neurophysiological, and molecular measures, and demonstrated relevancy to the therapeutic and adverse effects of the substance, and/or its use in neuropsychopharmacology research. Each statement is referenced with the original publication.

 

Photo history of neuropsychopharmacology

Photos of individuals with contributions to the development of neuropsychopharmacology. Each photo must be accompanied by a separate legend (subscript) in which each person in the photo is identified with his/her full name from left to right. In addition, the information in the legend must include the place and the year the photo was taken, as well as the name of the person to be acknowledged for receipt of photo.

 

Profiles of distinguished neuropsychopharmacologists

Vignettes of individuals who contributed to the development of neuropsychopharmacology, centered on the individual’s contributions to the field with each contribution referenced. Contributions must be presented chronologically with minimal biographical connecting information.

 

Controversies in the history of neuropsychopharmacology

Essays on controversies in the history of neuropsychopharmacology with an impact on the development of the field. Controversies of the past must be presented as overviews with a discussion of their consequences, whereas ongoing controversies must presented either as an impartial exposition of the controversy or as an argument in support of one side

 

Textbook on the History of Neuropsychopharmacology

A multi-authored edited text on the history of neuropsychopharmacology for general use by students, educators, researchers and clinicians. Each chapter covers a different area of the field from its inception to present in chronological order with information restricted to established knowledge.   The table of contents for the textbook is as follows:

1.       The birth of neuropsychopharmacology

2.       Research in neurophysiology on the effects of psychotropic drugs on the brain

3.       The development of behavioral pharmacology in the screening for psychotropic drugs

4.       Pharmaco-EEG in the detection of differential psychotropic effects

5.       The introduction of techniques for measuring CBF and brain metabolism in the study of psychotropic drugs

6.       The birth and development of neuropharmacology

7.       Neuropharmacology and psychotropic drug development

8.       Pharmacokinetic research with psychotropic drugs

9.       Pharmacogenetic research with psychotropic drugs

10.   Introduction and development of clinical trial methodology

11.   Pharmacotherapy and the diagnosis and classification of psychiatric disorders

12.   The story of pharmacotherapy with psychotropic drugs

13.   Model psychoses from mescaline to phencyclidine

14.   The story of endogenous psychotogens

15.   Neuropsychopharmacology: testing of neuropharmacological hypotheses

16.   Psychopathology and psychiatric nosology in neuropsychopharmacology research

17.   Development of pharmacotherapy in child psychiatry

18.   Development of pharmacotherapy in geriatric psychiatry

19.   Neuropsychopharmacology and endocrine psychiatry

20.   A history of pharmacological (addiction) psychiatry

21.   Fifty years of neuropsychopharmacology

 

Discoveries that have not been followed up and experiments that could not be replicated

Essays that give a full account of either a promising discovery that has not been followed up or of an experiment that could not be replicated with a discussion of possible reasons why the discovery has not been followed up or the experiment replicated. An example for a discovery that has not been followed up: David Janowsky and his associates’  finding that physostigmine, a cholinesterase inhibitor that increases acetylcholine concentrations, turned off mania and induced depression in some patients. An example for an experiment that could not be replicated: the findings of Wyatt and his associates that low monoamine oxidase activity in platelets was a genetic marker for schizophrenia.

Information on books in neuropsychopharmacology: classic and current

Reviews of books in neuropsychopharmacology published before 1990 (classic) or after (current). Reviews must be restricted to “Information on Contents,” in which the material covered in the book is presented chapter by chapter following its table of contents and to Reviewer’s Comments.  In case the review is written by the author or the editor, Reviewer’s Comments should provide background information to the writing/editing of the book. 

 

Biographies, autobiographies and selected writings of neuropsychopharmacologists

Reviews of autobiographies, biographies and selected or collected writings of individuals involved with neuropsychopharmacology for any period of time during their professional career. This section also includes obituaries (eulogies) in memory of neuropsychopharmacologists. Reviews or obituaries must include material on neuropsychopharmacology or reference material related to neuropsychopharmacology, but do not have to deal exclusively with information related to neuropsychopharmacology.

 

Historical perspective:  Information from and comments on current publications in neuropsychopharmacology

            Essays in which a currently published article or editorial related to neuropsychopharmacology is reviewed and commented on, or discussed in historical perspective.

 

Electronic archives in neuropsychopharmacology

Collections of unpublished papers and presentations, including power point presentations and slide shows, by individuals who contributed to the development of neuropsychopharmacology.  Entries in individual collections are acceptable even if incomplete, e.g., missing references. In the case where a title or first page does not provide the year when written, the entry must be accompanied by a preamble in which the date with other information on the entry is contained.

 

Educational e-books

Unpublished monographs in neuropsychopharmacology and collated documents based on postings on INHN’s website, specially edited for educational purpose.

 

Leon S. Morra

November 24, 2016